Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

127.48 +2.73 (+2.19%)
Streaming Delayed Price Updated: 2:58 PM EST, Feb 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
News headline image
3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort ↗
In a sector where picking individual stocks is a high-risk, high-reward strategy, the diversification of exchange-traded funds can be highly appealing. 
Via The Motley Fool
News headline image
Analyzing SPDR Series Trust SPDR S&amp;P Biotech ETF's Unusual Options Activity ↗
SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) shares experienced unusual options activity on Friday. The stock price moved up to $136.19 following the option alert.... 
Via Benzinga
Topics Stocks
News headline image
Leisure & Entertainment ETF (PEJ) and AMC Networks (AMCX) Caught In Meme Madness ↗
Dynamic Leisure and Entertainment ETF (PEJ) has been by far the best performer over the past week. 
Via Talk Markets
News headline image
A Fresh Dose of Biotech Perspective ↗
If the only thing that’s changed with your favorite biotech is the price, stay the course. Your bottom line will thank you for it later. 
Via Talk Markets
News headline image
Stocks Drop On Turnaround Tuesday As The Next Leg Lower May Have Begun ↗
It was not a good day for the Russell 2000. After failing to break out yesterday, it fell sharply today. 
Via Talk Markets
News headline image
Biotech Stocks Cruise Through The Volatility ↗
The XLV Healthcare Select SPDR is up 10% YTD. 
Via Talk Markets
News headline image
Medical Miracles Inside Biotech ETFs ↗
The events of the past year focused a lot of attention on game changing developments made possible by the global biotech industry. Of the major names Moderna is the one where the original research and... 
Via Talk Markets
Topics Intellectual Property
News headline image
Buy This Instead Of "Big Tech" Stocks And Bank 55% Gains ↗
Investors are bobbing laterally from sector to sector, searching for stocks to buy ahead of a traditional summer slowdown that could be made worse by worries about inflation. 
Via Talk Markets
News headline image
5 All-Star ETFs & Stocks to Buy on the Dip ↗
Here are the five ETFs that are currently undervalued and could generate solid returns in a rising stock market, and five stocks that are cheap and have the potential to deliver higher returns 
Via Talk Markets
News headline image
How To Profit In A $29 Billion “New Biotech” Sector ↗
Drug market companies haven’t exactly hit the S&P 500 yet; we’re still in “ground floor” territory. 
Via Talk Markets
Topics Stocks
News headline image
Biotech ETFs To Suffer As US Backs IP Waiver For COVID-19 Vaccines ↗
The Biden administration announced support for the waiver of intellectual property protections for COVID-19 vaccines proposed by South Africa and India. Let’s take a look at ETFs that can suffer from... 
Via Talk Markets
Topics Intellectual Property
News headline image
Buying This Beaten-Down ETF Could Make You a Fortune Over the Next 10 Years ↗
It definitely made investors a lot of money over the last decade. And its future could be brighter than the past. 
Via The Motley Fool
News headline image
Jon Najarian Sees Unusual Option Activity In SPDR S&P Biotech ETF And Verra Mobility ↗
On CNBC's "Fast Money Halftime Report," Jon Najarian gave some unusual options activity plays. Najarian sees unusual activity in: SPDR S&P Biotech ETF (NYSE:... 
Via Benzinga
Topics Stocks
News headline image
2 Must-Own Biotech Stocks To Buy In May ↗
After a stellar rally in 2020, biotech stocks have been selling off over the past couple of months. This offers investors a buying opportunity to scoop up quality biotech stocks such as Gilead Sciences... 
Via Talk Markets
News headline image
AskSlim Market Week - Friday, April 30 ↗
This video provides technical analysis, cycle analysis, and commentary regarding the movement in the markets throughout the past week. 
Via Talk Markets
News headline image
Best Biotech Stocks & ETFs for mRNA, Gene Editing ↗
2020 was the most challenging year in decades but it was great for scientific innovation, particularly in the biotech space. 
Via Talk Markets
News headline image
2 Must-Own Biotech Stocks to Buy in May ↗
After a stellar rally in 2020, biotech stocks have been selling off. But this drop offers investors a great buying opportunity. 
Via InvestorPlace
News headline image
Solar and Steel Shining, Biotech Bounces, and Miners Moving ↗
Given it had traded in oversold territory for most of the past two months, TAN’s recent rally has not even been enough to bring the ETF back above its 50-DMA. 
Via Talk Markets
News headline image
Capturing Average Returns With Asset Allocation, Part III ↗
There’s no reason to make intentionally poor asset allocation decisions when picking a set of funds. What happens when we apply a bit of common sense to the mix and look for opportunities to juice the... 
Via Talk Markets
News headline image
Stocks Drop On April 20 As Netflix Sinks ↗
Stocks fell for a second day, with the S&P 500 dropping by 70 bps, nothing too exciting. 
Via Talk Markets
Topics Stocks
News headline image
How To Play Lagging Healthcare Stocks ↗
The Healthcare Select SPDR Fund (XLV​​​​​​​) gives you the most diversified play in healthcare returning 11.4% in ’20 and 4% YTD. 
Via Talk Markets
News headline image
Stocks Trade Sideways As Volatility Rises And Biotech Sinks ↗
Stocks finished the day flat, with volume levels that continue to underwhelm. 
Via Talk Markets
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.